Met endpoint
RAP-219
Rapport Therapeutics RAPP
Stock move (first trade) +8.11%
Drug trial results and the stock moves that follow
21 resultsWins (met endpoint / approved)
Met endpoint
31 valent pneumococcal conjugate vaccine
Vaxcyte PCVX
24h stock move +29.23%
Met endpoint
Tabirafusp tedromer
Kodiak Sciences KOD
24h stock move +168.93%
Met endpoint
barzolvolimab
Celldex CLDX
24h stock move −11.59%
Met endpoint
DT120
Definium Therapeutics DFTX
24h stock move +4.78%
Met endpoint
Mosliciguat
Roivant ROIV
24h stock move +18.75%
Met endpoint
Avexitide
Amylyx Pharmaceuticals AMLX
24h stock move +66.59%
Met endpoint
NEO100
NeOnc Technologies NTHI
24h stock move −20.91%
Met endpoint
DT120
Definium Therapeutics DFTX
24h stock move +6.09%
Met endpoint
Divesiran
Silence Therapeutics SLN
24h stock move +30.88%
Met endpoint
Pemvidutide
Altimmune ALT
24h stock move +1.35%
Met endpoint
ML-007C
MapLight Therapeutics MPLT
24h stock move −73.66%
Met endpoint
ALXN1840
Monopar MNPR
24h stock move 0.00%
Met endpoint
Rituximab
ADC Therapeutics ADCT
24h stock move −55.84%
Met endpoint
TTX-MC138
TransCode Therapeutics Successfully RNAZ
24h stock move −12.20%
Met endpoint
ublituximab
TG Therapeutics TGTX
24h stock move −0.97%
Met endpoint
APG777
Apogee Therapeutics APGE
24h stock move −6.11%
Met endpoint
Rapamycin
Palvella Therapeutics PVLA
24h stock move +0.36%
Met endpoint
RGX-202
REGENXBIO RGNX
24h stock move −38.15%
Met endpoint
LUMRYZ
Alkermes plc. ALKS
24h stock move +7.13%
Met endpoint
AVTX-009 Regimen 1
Avalo Therapeutics AVTX
24h stock move +33.83%
Daily roundups
For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.